![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](su6265contents.gif)
Acta Cryst. (2006). E62, o911-o913 [ doi:10.1107/S1600536806003709 ]
Abstract: In the title compound [systematic name: 2,5,8,15,18,21-tricyclo[20.4.0.09,14]hexacosane-4-acetylaminobenzaldehyde thiosemicarbazone-methanol (1/2/2)], C20H36O6·2C10H12N4OS·2CH3OH, the cis-anti-cis-dicyclohexyl-18-crown-6 molecule resides on an inversion center, and two thiacetazone molecules are linked to the macrocycle via N-H
O hydrogen bonds of the terminal amino group [N
O = 3.017 (2) and 3.092 (2) Å]. These units are further associated into chains via bridging methanol molecules acting both as an H-atom donor [via an O-H
S contact, with O
S = 3.182 (3) Å] and as an H-atom acceptor [via an N-H
O contact, with N
O = 2.848 (3) Å].
Online 3 February 2006
Copyright © International Union of Crystallography
IUCr Webmaster